Testing semaglutide for cocaine use in adults
Treatments studied
Part of Infections, Mental health clinical trials.
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have used cocaine at least 7 out of the last 14 days and meet criteria for cocaine use disorder.
- Your body mass index (BMI) must be between 20 and 50.
- You cannot have diabetes or take medicines for high blood sugar.
- You cannot have taken semaglutide (Ozempic/Wegovy) or similar drugs before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.
This study tests whether a once-weekly injection of semaglutide (a GLP-1 receptor agonist) can reduce opioid use in people who are already on buprenorphine or methadone but still using opioids. It lasts about 19 weeks.
This trial tests if semaglutide, a medication that affects appetite and cravings, can help people reduce or stop using methamphetamine. It may be a new option for those struggling with moderate to severe methamphetamine use disorder.
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
Hear when a new Cocaine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.